to Explore International MedTech Collaboration Safe Implant Technology (SIT), a Danish MedTech company developing the patented GP5 technology, is participating in Singapore Week of Innovation and Technology (SWITCH) from 27–29 October 2026. The company is joining an international delegation organised through the Eureka …
Clarifying a Critical Distinction In discussions around implant immunology, confusion often arises between systemicimmunosuppression and localized immune modulation.These approaches are fundamentally different. Systemic Suppression Systemic immunosuppression influences immune activity throughout …
Integrating Immune Response into Risk Management Regulatory evaluation of long-term implants increasingly emphasizes sustained biological performance.Foreign body response and fibrotic encapsulation directly influence safety and clinical predictability. Foreign Body Response …
To make implantable medical devices safer, securer, and better for patients, Safe Implant Technology has developed and patented GP5.
Imagine having an implantable CGM that never has to be replaced or an abdominal mesh that won’t inflict pain. That’s what GP5 can do for patients across medical device types and brands.
Safe Implant Technology was founded with a vision to address the challenges posed by adverse immune reactions triggered by implantable medical devices. The company’s journey began with extensive research into understanding the underlying causes of these reactions. We established Mechanism of Action with GP5, a pioneering product that suppressed immunological responses, and form a proprietary surface coating that reduced complications and improved patient outcomes. Safe Implant Technology’s dedication to innovation and patient well-being led to seek regulatory approval and funding for the development of a generic surface coating for all implantable medical devices.
Safe Implant Technology envisions a future where implantable medical devices are safer, biocompatible, and offer improved outcomes for patients. We strive to be at the forefront of medical development, continuously innovating our generic surface coating GP5 to minimize immune reactions and ensure the long-term integrity and functionality of medical implants.
Safe Implant Technology’s mission is to develop and provide medical device surface coatings that decrease immune reactions, improve biocompatibility, and reduce post-operative complications. We aim to create a lasting impact on the field of medical technology, contributing to better patient experiences and ensuring the well-being of implant recipients worldwide. To achieve this mission, Safe Implant Technology seeks to establish a robust data foundation, conduct clinical studies, and obtain regulatory approval for the surface coating GP5, adhering to the highest standards of safety and effectiveness.
Safe Implant Technology are formed by a group of highly competent and specialized persons having more than 70 years of experience from life science, biotech and medtech industries.
